Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM0HAC8)

Drug Name

Cerliponase Alfa Drug Info

Synonyms

Brineura

Indication

Disease Entry	ICD 11	Status	REF
Neuronal ceroid lipofuscinosis	5C56.1	Approved	[1]
Tripeptidyl peptidase 1 deficiency	5C50	Approved	[2]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Tripeptidyl-peptidase I (TPP1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
LX1004	DMKRZ0R	CLN2 Batten disease	5C56	Phase 1/2	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2018
2	2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.
3	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
4	Clinical pipeline report, company report or official report of Lexeo Therapeutics